Abstract
Preterm birth (PTB) remains one of the leading causes of neonatal mortality and long‐term morbidity worldwide, with minimal progress being made in reducing its incidence, particularly in low‐resource settings. Preconception care is recognized as an effective strategy for PTB prevention; however, the fact that more than half of pregnancies globally are unplanned significantly limits opportunities for successful intervention. These FIGO good practice recommendations advocate shifting from pregnancy‐centered care to woman‐centered care and promote the integration of a baby‐centered assessment into preconception care. This approach allows for the early identification and management of modifiable risk factors for PTB across various domains, including medical, obstetric, nutritional, infectious, psychological, and socio‐environmental factors. The review emphasizes the importance of evidence‐based interventions during the preconception period and underscores the need for policy and advocacy initiatives to promote equitable access to preconception services.
Keywords: FIGO guidelines, preconception care, preterm birth, prevention
1. BACKGROUND
1.1. The frustration of being late
Connecting with a baby born too soon and its family presents maternal−fetal health teams with a situation that could have been prevented. It is inevitable to feel the regret of arriving too late to an avoidable outcome.
Globally, one in 10 babies is born prematurely. Preterm birth rates have not improved over the past decade, and in some areas they are rising. Preterm birth is the leading cause of death among children under 5 years of age, accounting for more than one in three neonatal deaths. According to the latest Born Too Soon report, neonatal conditions remain the leading cause of human capital loss in recent global burden of disease estimates. Sadly, figures have not changed since 1990. 1
Despite recent technological advances, survival rate gaps exist between high‐ and low‐income communities. Moreover, the so‐called four Cs (conflict, climate change, COVID‐19, and cost‐of‐living crises) have deepened the vulnerability of preterm babies and their families in these contexts. 1
The World Health Organization (WHO) has advocated for preconception care to prevent preterm birth. However, developing a global policy on this topic is challenging due to the various stakeholders involved. 2 The International Federation of Gynecology and Obstetrics (FIGO) has recently released a position statement on the subject, highlighting its role in women's health care. 3
The objective of this document is to provide a complementary perspective to the FIGO preconception checklist, 3 highlighting the benefits of preconception care to mitigate preterm birth. It aims to recognize every woman of reproductive age as an integral part of the mother–baby dyad. Based on this premise, we propose an approach that originates “from the grassroots,” empowering women and children with their rights. This approach offers resources to maternal–fetal healthcare providers and policymakers for effective education, support, counseling, and interventions. The ultimate goal is to prevent preterm birth through comprehensive preconception care. By focusing on empowerment and resource allocation, we aim to enhance the quality of maternal and fetal health, ensuring that preconception care becomes a pivotal aspect of healthcare planning and delivery. This document advocates for a proactive stance, emphasizing prevention and early intervention as key strategies for improving outcomes for mothers and their future children.
2. THE SIGNIFICANCE OF PRECONCEPTION CARE IN THE PREVENTION OF PRETERM BIRTH
The statement on preconception care for mothers and babies, recently developed by the FIGO Committee on Well Woman Healthcare and the FIGO Committee on the Impact of Pregnancy on Long‐Term Health, 3 emphasizes the critical role of preconception care in prevention of pregnancy complications and adverse outcomes. It highlights that the prepregnancy period offers a unique opportunity to encourage women to adopt healthy behaviors before pregnancy, ultimately benefiting their children's health when they become pregnant. 3 Here we provide evidence highlighting the significant role preconception care might play in preventing preterm birth.
The FIGO preconception checklist for women of childbearing age starts with a key question: “Are you planning to become pregnant in the next six months?” However, over 50% of pregnancies in high‐income countries are unplanned. 3 This percentage is even higher in low‐income countries and communities affected by social or economic crises. 1
Since most women have the potential to conceive a child at some point during their reproductive years, regardless of their specific plans or intentions, this question might undermine that possibility, leaving them and their future children unprotected or vulnerable.
Rather than solely asking whether someone is planning a pregnancy, we recommend offering clear, supportive information about how pre‐pregnancy health can influence outcomes for both the parent and the child. Unintended pregnancies might carry increased health risks, including a higher likelihood of complications such as preterm birth, early infant loss, and long‐term developmental challenges. In this light, a more meaningful question could invite discussion around the potential risk of preterm birth for all individuals of reproductive age, creating an opportunity to provide compassionate guidance and tailored counseling that supports informed choices and well‐being:
Even if you're not yet certain about your plans, taking steps to prepare for pregnancy in advance can make a meaningful difference. It helps reduce risks like preterm birth and supports a healthier start for both you and your future baby. Would you like to explore how simple changes now can benefit your pregnancy later?
Here, we review the evidence regarding risk factors associated with preterm birth and propose recommendations that, when employed in conjunction with the FIGO preconception checklist, might assist in planning personalized interventions to prevent this adverse outcome.
3. RISK FACTORS ASSOCIATED WITH PRETERM BIRTH
Both the preconception and postnatal periods present opportunities to advise on optimal women's health in preparation for a subsequent pregnancy. Moreover, clinical conditions that might lead to adverse perinatal outcomes, such as preterm birth, can be prevented or managed. In addition to those mentioned in the document published by the FIGO Committee on Well Woman Health Care and the FIGO Committee on the Impact of Pregnancy on Long‐Term Health, we strongly recommend considering risk factors that influence the duration of pregnancy.
3.1. Maternal age
Adolescent pregnancy
Adolescents face an increased risk of preterm birth due to a higher prevalence of preeclampsia, preterm pre‐labor rupture of membranes (PPROM), anemia, and sexually transmitted infections. From a psycho‐social standpoint, pregnant adolescent girls in certain cultures and regions frequently experience feelings of guilt, financial difficulties, challenges in continuing their education, and social stigmatization. 4
Preterm birth in adolescent women is associated with a low number of prenatal visits, late onset of prenatal care, and low educational level. Moreover, a Brazilian study consisting of 23 894 postpartum women and their newborn infants found that younger adolescents had the highest risk of spontaneous preterm birth compared to older adolescents. 5
Appropriate counseling about the risks of maternal–perinatal adverse outcomes, encouragement to fulfill personal expectations and exercise reproductive rights, and help to make healthy decisions should be offered to every adolescent person, if possible, before starting sexual activity, to avoid unplanned pregnancy, sexually transmitted disease, and preterm birth.
Advanced age pregnancy
Although current terminology defines pregnant women over 35 years of age as being of “advanced maternal age,” there is no absolute consensus on this definition, as the potential for conception persists until menopause. Female fertility is more closely related to biological rather than chronological age. 6 Advanced maternal age is associated with an increased risk of adverse pregnancy outcomes, particularly in women over 40 years of age. Several studies report higher rates of chromosomal abnormalities, spontaneous abortions, and preterm births in this group. 7 The risk of preterm birth follows a U‐shaped curve, with the lowest risk observed between 30 and 34 years of age and higher risks seen in both younger and older mothers. 8
Factors contributing to preterm birth in women of advanced maternal age can be categorized into two main groups: the higher prevalence of comorbidities; and pregnancy‐specific complications such as gestational diabetes, preeclampsia, and placental abnormalities. Further, women who conceive at older ages are more likely to undergo pregnancies through assisted reproductive techniques, which are associated with an increased risk of preterm birth. 7 , 8 , 9 , 10 Women aged 50 years or older face a significantly higher risk, with studies indicating at least a threefold increase compared to younger age groups. 11
Preconception counseling and personalized care are recommended for women planning to become pregnant after the age of 35 years to optimize their health and mitigate preterm birth risks.
3.2. Obstetrical and gynecological conditions
The assessment of health status before pregnancy is essential for women of all reproductive ages, regardless of their parity. To assess the risk of preterm delivery in multiparous patients, it is essential to evaluate the following risk factors.
History of spontaneous preterm birth
A previous pregnancy resulting in spontaneous preterm birth or mid‐trimester loss is the primary risk factor for a subsequent preterm birth. The overall risk of recurrence of preterm birth in singleton pregnancies is estimated to be around 20%. 12 However, this risk varies depending on the gestational age at which the previous preterm birth occurred and the number of preterm and term deliveries the patient has experienced in the past. Specifically, the earlier the gestational age or frequency of preterm delivery, the higher the risk of recurrence. 13 Additionally, a history of spontaneous PPROM significantly increases the risk of PPROM (odds ratio [OR] 20.6; 95% confidence interval [CI], 4.7–90.2) and preterm delivery in subsequent pregnancies (OR 3.6; 95% CI, 2.1–6.4). 12
History of preeclampsia
A history of early preeclampsia that has resulted in preterm delivery has a risk of recurrence of 15%, 14 which in turn poses a risk of indicated or iatrogenic preterm delivery in subsequent pregnancies. This is especially true in many low‐ and middle‐income countries, where preeclampsia is prevalent. A study published in Brazil that included 20 hospitals and 33 740 women showed that the main cause of iatrogenic preterm birth was preeclampsia. 15 Early identification of an increased risk of preeclampsia during a pre‐conception assessment enables the early initiation of preventive measures, such as aspirin during a subsequent pregnancy.
Previous cesarean section at full cervical dilatation
Some evidence suggests that emergency cesarean section (CS) performed during labor is associated with an increased risk of spontaneous second‐trimester miscarriage or spontaneous preterm birth (sPTB) in a subsequent pregnancy (relative risk [RR] 2.71; 95% CI: 1.87–3.87). 16 , 17 This risk appears to rise with the degree of cervical dilatation at the time of CS, reaching its peak at full dilatation. The mechanisms underlying this association remain unclear; however, incisional trauma to the lower uterine segment might also compromise the tissue fibers of a fully effaced and dilated cervix, resulting in cervical insufficiency in future pregnancies.
Although prospective studies are required to confirm the causal relationship between CS and sPTB, preconceptional assessment should include detailed information on the nature and timing of previous cesarean deliveries to enable adequate risk stratification and targeted prenatal surveillance.
Short pregnancy interval
Short interpregnancy intervals (IPIs), particularly when shorter than 6 months, have been reported to be associated with increased risk of preterm birth. A systematic review and meta‐analysis involving more than 8.6 million pregnancies demonstrated that women with IPIs of less than 5 months had a higher risk of preterm birth before 32 weeks (OR: 1.82; 95% CI: 1.55–2.14) and before 37 weeks of gestation (OR: 1.64; 95% CI: 1.42–1.90), compared to those with IPIs of 24 to 29 months. 18 Similarly, a multicenter study conducted in Latin America, based on a cohort of 894 476 women, found that IPIs shorter than 12 months were associated with an increased risk of preterm birth (adjusted OR: 1.16; 95% CI: 1.11–1.21), neonatal mortality, and preeclampsia. 19 A recent meta‐analysis has also confirmed this observation. 20
In light of the evidence, the WHO recommends a minimum interval of 18 to 24 months between pregnancies. However, more prospective data is needed to provide individualized recommendations for otherwise healthy women regarding the timing between pregnancies.
Need for assisted reproductive techniques
Evidence from numerous studies has demonstrated that pregnancies conceived via assisted reproductive technologies (ART), including in vitro fertilization (IVF) and intracytoplasmic sperm injection, are associated with a significantly increased risk of preterm birth (PTB), even in singleton gestations. A meta‐analysis involving over 16 million pregnancies demonstrated a 1.72‐fold increased risk of PTB before 37 weeks and a 2.19‐fold increased risk of very preterm birth (<32 weeks) among ART conceptions compared to spontaneous pregnancies. Elevated rates were observed for both iatrogenic and spontaneous PTB, with a notably higher incidence following fresh embryo transfer versus frozen. 21
Further support comes from retrospective and population‐based cohort studies in Italy and China, which consistently show increased PTB rates in ART pregnancies, independent of multifetal gestation. Procedure‐specific factors, such as embryo reduction, have been identified as additional contributors to PTB risk. 22 , 23
Further, the use of single embryo transfer (SET) has emerged as an effective strategy for mitigating the risk of preterm birth associated with ART. A comprehensive meta‐analysis of 85 studies revealed that SET, when compared to double embryo transfer (DET), is associated with a 75% reduction in the risk of PTB (OR: 0.25; 95% CI: 0.21–0.30). This substantial decrease is attributed mainly to the lower incidence of multiple pregnancies, underscoring the preventive value of SET in ART protocols. 24
In light of these findings, FIGO recommends minimizing ART‐related PTB risk by limiting ART use to cases where less invasive methods have failed, promoting single embryo transfer, and minimizing embryo manipulation during culture and transfer. FIGO also emphasizes the importance of comprehensive preconception assessment and individualized risk stratification, noting that even singleton IVF pregnancies might carry an inherent risk of PTB due to factors related to embryo handling or underlying infertility. 25
Collectively, these findings emphasize the critical need for tailored prenatal care and preventative strategies aimed at mitigating both spontaneous and iatrogenic PTB in ART‐conceived pregnancies.
Congenital uterine abnormalities
Women with congenital uterine anomalies or Müllerian malformations face a significantly higher risk of preterm birth, with reported rates reaching 26.8%. 26 This is more than double the rate observed in the general population and can vary based on the type of anomaly. For example, the risk might be as high as 60% in cases of unicornuate uteri and 34.5% for didelphys uteri. 27 , 28
Preconception counseling is crucial for evaluating individual risk factors and guiding management strategies. Advanced imaging techniques, such as three‐dimensional ultrasound and magnetic resonance imaging, enable early diagnosis and surgical correction in selected cases, such as hysteroscopic metroplasty for septate uteri. When surgical intervention is not feasible, as in cases of unicornuate or bicornuate uteri, counseling plays a vital role in anticipatory planning. This might include close monitoring, cervical length assessments, and consideration of interventions such as progesterone therapy or cervical cerclage. 26
Cervical surgery
A history of cervical surgery is a recognized risk factor for PTB, with the degree of risk influenced by the extent of cervical tissue excision and the invasiveness of the procedure. Data from a systematic review and meta‐analysis indicate that the RR of delivery before 37 weeks is significantly increased following large loop excision of the transformation zone (RR 1.61; 95% CI: 1.35–1.92) and even more after cold knife conization (RR 2.59; 95% CI: 1.80–3.72). However, when women with comparable grades of dysplasia who did not undergo excisional procedures were used as controls, the increased risk was not statistically significant, suggesting that part of the underlying cervical dysplasia might contribute independently to adverse pregnancy outcomes. 29
Further evidence from a large population‐based study in Sweden supports this interpretation, demonstrating that the risk of PTB was particularly elevated in women diagnosed with cervical intraepithelial neoplasia (CIN) during pregnancy, especially in those with a prior history of excisional treatment. Cone length emerged as an independent predictor of PTB, and the highest risk was observed in women with both a history of cervical surgery and concurrent CIN, suggesting a potential additive effect. 30 In addition to structural cervical compromise, recent findings have identified a biological mechanism involving impaired local immune defense. Specifically, prior excisional treatment was associated with a significantly increased risk of intraamniotic infection (IAI) in pregnancies complicated by PPROM. 31 More extensive procedures, such as laparoscopic radical trachelectomy are associated with markedly elevated PTB rates, reaching 60% in some cohorts, with most deliveries occurring between 32 and 36 weeks, despite a relatively high live birth rate of 71.4%. 32
In the context of preconception counseling, women with a history of cervical surgery should be carefully assessed for obstetric risk. A detailed surgical history should be obtained, including type of procedure, cone length, and indication. Patients should be counseled on their potentially increased risk of PTB and related complications, including PPROM and IAI. In cases of significant prior excision or additional risk factors (e.g., prior PTB, concurrent CIN), referral to a maternal–fetal medicine specialist might be warranted. Cervical length surveillance via transvaginal ultrasound in early and mid‐pregnancy should be planned, and the potential use of prophylactic interventions, such as vaginal progesterone or cervical cerclage, can be discussed when indicated. This proactive approach allows for individualized risk mitigation strategies and supports informed reproductive planning.
3.3. Pre‐existing medical conditions
Most pre‐existing medical conditions pose a risk of spontaneous or indicated preterm birth in women who have them. The range of autoimmune diseases, such as lupus or rheumatoid arthritis, cardiovascular conditions like chronic hypertension or congenital heart disease, kidney and liver disease, or cancer, are pathologies that are commonly associated with an increased risk of complications that might lead to iatrogenic preterm birth or its spontaneous onset. Although it is true that the risk linked to many of these conditions cannot be modified, assessing maternal health status in the pre‐conception period enables informed decision‐making regarding the risks of a potential pregnancy, as well as appropriate management and control of the disease prior to pregnancy, including the planning of effective therapeutic measures that are compatible with gestation and lactation.
Endocrine‐metabolic dysfunction
Maternal diabetes is associated with adverse maternal and neonatal outcomes. Although preterm birth appears to be more frequent in patients with pregestational diabetes mellitus than in women with gestational diabetes, 33 a recent meta‐analysis that included 108 studies showed that gestational diabetes mellitus significantly increases the risk of preterm birth in both singleton and twin pregnancies. 34
According to the results of a systematic review, preconception care in women with diabetes mellitus might decrease the risk of preterm delivery by 15%, highlighting its significance in preventing preterm birth. 35
Recent research has also identified a significant link between thyroid dysfunction and the risk of preterm birth. A systematic review and meta‐analysis found that both overt hypothyroidism and hyperthyroidism significantly increase this risk. 36 Another meta‐analysis indicated that subclinical hypothyroidism, isolated hypothyroxinemia, and the presence of anti‐peroxidase antibodies are also associated with an elevated risk of preterm birth. 37
Treatment of subclinical hypothyroidism has shown promising results in specific patients, such as thyroid antibody‐positive women 38 , 39 and euthyroid women with positive anti‐peroxidase antibodies. 40 However, further research is needed to support the universal implementation of screening and intervention strategies and confirm levothyroxine's efficacy in preventing preterm birth across various thyroid conditions. 41
3.4. Mental health issues
Psychiatric disorders
Women with psychiatric disorders are at increased risk of preterm and early term birth, which can negatively affect offspring health. A Swedish nationwide cohort study involving over 1.5 million births reported a significantly higher incidence of preterm births among children of parents, especially mothers, with psychiatric diagnoses such as schizophrenia, mood disorders, anxiety disorders (e.g., obsessive‐compulsive disorder and generalized anxiety), and stress‐related conditions. 42
The Norwegian Mother and Child Cohort Study (MoBa), which included over 81 000 pregnancies, found that high maternal trait anxiety (≥ + 2 SD above the mean) was independently associated with increased risks of late preterm (adjusted OR 1.7) and early term birth (adjusted OR 1.4). These associations remained significant after controlling for obstetric, demographic, and behavioral confounders and were observed in both spontaneous and provider‐initiated deliveries. Potential mechanisms include maternal hypothalamic–pituitary–adrenal axis dysregulation, subclinical inflammation, and altered placental function. Trait anxiety also correlated with higher rates of elective obstetric interventions, potentially affecting gestational length. 43
Given these findings, systematic screening for psychiatric and neurodevelopmental disorders in individuals of reproductive age, especially maternal anxiety, is recommended. Early intervention could improve maternal mental health and reduce adverse perinatal outcomes, including preterm birth.
Eating disorders
Eating disorders are significantly associated with an increased risk of preterm birth, with the global risk being 1.31 times higher compared to controls. According to a retrospective cohort study, Anorexia nervosa has the most significant association with preterm birth, followed by Eating Disorders Not Otherwise Specified and bulimia nervosa. 42 , 44
3.5. Nutrition and nutrient deficiencies
Underweight
There is a nonlinear relationship between maternal body mass index (BMI) and PTB risk, with the lowest risk observed in women with a BMI between 22.5 and 25.9 kg/m2. 45 Underweight women (<18.5 kg/m2) have a spontaneous PTB rate of 10.1%, 46 a risk that increases with the severity of underweight, with an adjusted RR (aRR) ranging from 1.22 to 1.61. 47 A systematic review of 78 studies (1 025 794 women) reported a higher PTB risk in underweight women (aRR 1.29; 95% CI: 1.15–1.46), affecting both spontaneous (aRR 1.32; 95% CI: 1.10–1.57) and induced PTB (aRR 1.21; 95% CI: 1.07–1.36). 48 These effects persist regardless of gestational weight gain, likely mediated by nutritional deficiencies, inflammation, and placental dysfunction. 49
Therefore, implementing strategies to optimize pre‐pregnancy nutritional status is recommended, including individualized nutritional assessment, specialized dietary counseling, and supplementation with essential micronutrients (e.g., iron, folic acid, and zinc), while promoting appropriate weight gain before conception as an effective measure to reduce the risk of preterm birth.
Overweight and obesity
Obesity also increases PTB risk, particularly for extremely preterm births (<28 weeks). A Swedish cohort (over 1.5 million births) showed that this risk is independent of comorbidities. 50 An English study of nearly 480 000 births revealed a J‐shaped association, with the highest odds in class IIIb obesity (aOR 2.80; 95% CI: 1.31–5.98). 51 While comorbidities mediate risk for medically indicated PTB, extreme obesity remains a risk factor for spontaneous PTB. Healthy lifestyle habits offer partial protection, and a “health‐conscious” diet modestly reduces spontaneous PTB risk, independent of BMI, 52 suggesting the influence of modifiable nutritional factors.
Collectively, these findings support the implementation of preconceptional public health strategies aimed at reducing maternal obesity to mitigate preterm birth risk. Such interventions should ideally be tailored to obesity severity and accompanied by lifestyle counseling to optimize maternal health before and during pregnancy. 53
Iron deficiency
Iron deficiency anemia is linked to an elevated PTB risk, especially in the first trimester. A meta‐analysis found a RR of 1.56 (95% CI: 1.25–1.95), increasing to 1.65 (95% CI: 1.31–2.08) in early pregnancy. 54 A case–control study further identified anemia as an independent PTB risk factor (aOR 2.69; 95% CI: 1.46–4.95). These findings underscore the importance of early detection and treatment of anemia during pregnancy as a critical strategy to reduce the risk of preterm birth. 55 , 56
Omega‐3 fatty acids supplementation
The evidence regarding omega‐3 fatty acid supplementation remains inconclusive. A systematic review of 26 trials (over 20 000 women) and a large randomized trial found no reduction in PTB or early PTB. 57 , 58 However, docosahexaenoic acid supplementation might reduce early PTB risk, 59 warranting further investigation through well‐designed clinical trials.
3.6. Lifestyle variables
Tobacco, alcohol, and substance use
Tobacco, alcohol, and psychoactive substance use during pregnancy are significant risk factors for PTB. Maternal smoking, particularly heavy smoking (≥10 cigarettes/day), is strongly associated with increased risk of very early PTB (<32 weeks), with an adjusted OR (aOR) of 1.39 (95% CI: 1.20–1.60). 60 Smoking negatively affects placental function and fetal oxygenation and is linked to placental abnormalities and infections. 61 The EUROPOP study found that smoking increased PTB risk across most obstetric complications, except hypertension, especially in multiparous women. 60
Alcohol consumption, particularly heavy or binge drinking, is associated with increased risk of prematurity and low birth weight, although evidence for a consistent effect on overall PTB rates is mixed. 62 Psychoactive substances such as cocaine, opiates, and cannabis elevate PTB risk by impairing placental blood flow and fetal development. 62 , 63 Cocaine and marijuana, especially when combined with tobacco, are major contributors to PTB and fetal growth restriction. 64 Additionally, substance abuse‐related mental disorders are linked to a 1.3‐fold increased PTB risk. 42
These findings emphasize the importance of comprehensive prenatal care, including early screening and interventions to address substance use, as well as strategies to mitigate socioeconomic disparities.
Physical activity
A cohort study on 87 232 singleton pregnancies included in the Danish National Birth Cohort between 1996 and 2002 showed a reduced risk of preterm birth among the almost 40% of women who were engaged in any exercise during pregnancy in comparison with those who were not (hazard ratio = 0.82, 95% CI 0.76, 0.88). Still, no dose–response or type of exercise relation was seen. No difference was seen when the degree of preterm birth was considered. 65
3.7. Infections
Sexually transmitted diseases
HIV–AIDS
HIV‐positive pregnant women demonstrate a 3–4‐fold increased risk of preterm birth compared to HIV‐negative counterparts. 66 , 67 The role of combination antiretroviral therapy (ART), particularly protease inhibitor‐based regimens (e.g., ritonavir‐boosted), in this association remains controversial, with several studies suggesting increased risk of preterm delivery. 67 , 68 Timing of ART initiation is a potential confounder due to selection bias. 66 , 69 Ongoing investigations are evaluating vaginal progesterone supplementation as a preventive intervention in women on protease inhibitor‐based ART. 66 , 70
Syphilis
Despite widespread screening availability, Treponema pallidum infection persists globally and has resurged in prevalence. Congenital syphilis is associated with preterm birth and other adverse outcomes. 71 Early detection via routine and preconception visits remains a critical prevention strategy.
Hepatitis B virus infection
Chronic hepatitis B virus infection is associated with a 16% increased risk of preterm birth, rising to 21% among HBsAg+/HBeAg+ women, 72 , 73 with findings corroborated by more recent data. 74 Preventive strategies include vaccination and preconception screening.
Human papilloma virus
Evidence on the link between human papilloma virus (HPV) and preterm birth is mixed. Persistent HPV infection, especially types 16 and 18, has been associated with increased risk of preterm birth, preterm prelabor rupture of membranes (pPROM), and neonatal mortality. 75 , 76 , 77 The risk is higher in women with treated high‐grade CIN. 78 Detection of HPV in both the cervix and the placenta correlates with adverse outcomes, including miscarriage. 79 These observations underscore the need for further studies into HPV pathophysiology and vaccine impact during pregnancy. 75
Trichomonas vaginalis
Meta‐analyses confirm associations with low birth weight, preterm birth, and prelabor rupture of membranes (PROM). 80 , 81 Coinfection with bacterial vaginosis is common (40%–60%) and might increase susceptibility. 82 Considering that Trichomonas vaginalis infection can be easily diagnosed and treated, it should be regarded in everyone of reproductive age.
Ureaplasma colonization
A meta‐analysis involving 11 990 pregnant women found that Ureaplasma colonization increased the risk of preterm birth (OR 2.76, 95% CI 1.63–4.68), chorioamnionitis (OR 2.71, 95% CI 2.02–3.64), and PROM (OR 2.19, 95% CI 1.34–3.58). 83 However, due to low‐quality evidence, well‐designed studies are needed to confirm these findings. 83 , 84
Other infections
Toxoplasmosis
A multicenter cohort study showed that congenital Toxoplasma gondii infection was associated with an increased risk of preterm birth when seroconversion occurred before 20 weeks of gestation (OR 4.71; 95% CI: 2.03, 10.9). 85
Cytomegalovirus
The overall birth prevalence of cytomegalovirus (CMV) congenital infection is approximately 0.67%, with a higher incidence among preterm neonates and those born to seropositive mothers. 86 Possible maternal primary infections (i.e., a seropositive mother with CMV IgM) result in congenital infections approximately 20% of the time. Still, they likely represent a mixture of primary and recurrent infections. 87
Vectorial diseases
Observational studies have shown that perinatal malaria infection increases the risk of a preterm delivery 2.5 times. 88 , 89 Searching for malaria in preconception care is essential because many women remain asymptomatic or have submicroscopic parasitemia, and the time parasite burden and the timing of infection might modify perinatal outcomes. 90 In endemic zones, Trypanosoma cruzi perinatal infection (Chagas disease), through placental disease that occasionally occurs, might increase the risk of preterm birth. 91 , 92 Preconception care might help detect seronegative women who could be at risk of acute infection during pregnancy. Regarding viral infections, such as Dengue or Zika, there is no difference in preterm birth prevalence for women with and without dengue (DENV) or Zika virus infection. 92 , 93 However, DENV infection in pregnant women might be associated with maternal mortality, stillbirth, and neonatal mortality. 92
Periodontal and dental health
Gingivitis, periodontal disease, and dental damage are associated with chorioamnionitis and preterm birth. 94 , 95 Preconception care can preserve women's oral health through education and professional assistance.
3.8. Socioeconomic issues
Maternal occupation
A systematic review and meta‐analysis found moderate evidence that high physical workload, long working hours, shift work, and whole‐body vibration during pregnancy increase the risk of preterm birth. Moreover, physical overload is associated with rising rates of medically indicated and spontaneous very preterm birth. In addition to physical demands, psychological mechanisms such as fatigue, stress, sleep deprivation, and circadian rhythm disruption are involved in this association. 96
Although further research is needed to investigate the effect of occupational risks on preterm birth, women of reproductive age should be informed about the potential risk of preterm birth associated with working risks, health providers should conduct screenings, and policymakers should implement protective measures.
Domestic violence
A systematic review involving more than 70 000 women showed that those who suffer intimate partner violence are 2.32 times more likely to give birth preterm. 97 Other forms of sexual violence have been associated with significantly more hospitalizations during pregnancy, primarily due to hyperemesis gravidarum and threatening preterm birth. 98
Preconception care should be considered an opportunity to advocate for women's and people‐to‐be‐borns' rights. Education and social awareness should be promoted, and gender violence should be addressed among all women of reproductive age, whether they are planning pregnancy or not.
Homeless status
A cross‐sectional study that included 18 970 pregnant women showed in a multivariate analysis that homeless status is an independent risk factor for extreme preterm delivery (<28‐week gestation: 34.3 vs. 10.8 per 1000 deliveries; adjusted OR [AOR], 2.76 [95% CI, 2.55–2.99]). 99
3.9. Exposure to toxic environmental chemicals
Although the relationship between environmental chemical exposures and PTB has been widely studied, results remain inconclusive. Maternal and fetal overexposure to heavy metals during pregnancy has been associated with PTB and reduced birth size; however, recent data suggest a potential link between heavy metals and altered birth anthropometrics. 100
Regarding endocrine‐disrupting chemicals, research in different communities showed a positive association between high bisphenol A urinary levels and preterm birth. 101 , 102 Published evidence reveals a significant association between phthalate exposure and preterm birth, but it is still not clear which specific phthalates are more harmful. 103 , 104
Organophosphate pesticides have been especially implicated, potentially increasing PTB risk through fetal neurotoxicity. 105 While their association with PTB is supported, variables such as timing of exposure and fetal sex require further study. 106 , 107 , 108 Additionally, organochlorine pesticides are linked to PTB, although larger population studies are necessary to influence policy, particularly in countries where these compounds remain in use. 109 , 110 , 111
Other industrial chemicals in electronics, personal care products, toys, and clothing have also been associated with PTB. The evidence linking lead exposure and polybrominated diphenyl ethers (flame retardants) to PTB is inconsistent, mainly due to small sample sizes. 112 , 113
Although the findings of studies differ, they collectively show enough evidence of a potential association between a toxic environment and the risk of preterm birth. Healthcare providers should enquire about exposure in individual patients of reproductive age, while policymakers should be encouraged to limit it globally and monitor population levels.
4. PRECONCEPTION INTERVENTIONS FOR THE PREVENTION OF PRETERM BIRTH: DO THEY WORK?
No matter how early women begin their prenatal visits, they arrive late to prevent most of the adverse maternal and perinatal outcomes. That is why many national and international organizations suggest preconception healthcare promotion at every encounter a person of reproductive age has with the healthcare system. 114
Although the generally recommended mechanisms are based on three axes (screening, promotion, and intervention or referral), these components are rarely translated into practical tools for action and decision‐making in the clinical setting. However, there are many conditions for which scientific evidence has demonstrated that clinical interventions effectively improve pregnancy outcomes, including preterm birth (Table 1). 54 , 56 , 114
TABLE 1.
Selected risk factors associated with preterm birth for which evidence‐based preconception care recommendations have been developed.
| Risk factor | Evidence‐based intervention |
|---|---|
| Neural tube defects | Folic acid supplementation |
| Rubella sero negativity | Immunization |
| Preconception diabetes | Proper management |
| Hypothyroidism | Diagnosis and/or proper treatment |
| HIV infection/AIDS | Diagnosis and timely treatment |
| Phenylketonuria | Low phenylalanine diet |
| Oral anticoagulants | Change medication |
| Antiepileptic drugs | Change medication and/or adjust treatment |
| Isotretinoin | Contraception during treatment |
| Smoking | Cessation |
| Alcohol misuse | Cessation |
| Obesity | Weight loss |
| Nutritional factors | Healthy diet |
| Sexually transmitted diseases | Prevention, screening and treatment |
| Hepatitis B | Immunization |
| Iron deficiency | Screening and iron supplementation |
5. RECOMMENDATIONS FOR PRECONCEPTION RISK ASSESSMENT AND INTERVENTIONS TO REDUCE PRETERM BIRTH
As we have already seen, more than 50% of pregnancies are unplanned, so we believe it necessary to search for risk factors that might lead to adverse perinatal outcomes in every woman of reproductive age. Thus, health providers would be able to intervene before an eventual pregnancy takes place. In recent decades, research has shown that providers are more likely to engage in evidence‐based practices following participation in quality improvement projects. 115 , 116 , 117 Therefore, innovative approaches for bundles of interventions might help decrease preterm birth through better preconception care.
Considering unplanned pregnancy as a global issue and that many women who intend to plan pregnancy have an increased risk for preterm birth, we propose a set of evidence‐based recommendations to apply when specific risk assessment should be made, to offer appropriate counseling and apply any required interventions to reduce the probability of preterm birth.
5.1. Evidence‐based recommendations and interventions
Maternal age
Conduct a comprehensive evaluation of adolescents, including sexual activity, behavioral habits, individual expectations, and their psychosocial and family environment.
Empower adolescents to pursue personal goals and exercise their reproductive rights with autonomy and informed decision‐making.
Counsel every adolescent person to make healthy decisions about unplanned pregnancy and sexually transmitted diseases.
Provide counseling about the risks of preterm birth and the consequences of being born too soon to families and children, to every woman of reproductive age.
Provide counseling and encourage self‐awareness about the significantly heightened risk of preterm birth in women under 19 and over 35 years old, whether they intend to plan a pregnancy or not.
Obstetrical and gynecological conditions
Counsel all women with a history of preterm birth about their significantly increased risk of experiencing preterm birth again and assess their cervical length.
Counsel all women with a history of preeclampsia about their significantly increased risk of recurrence, leading to a significant probability of preterm birth.
In patients with a history of previous CS, assess the timing (first or second stage) and nature (elective or emergency) to ensure appropriate surveillance in subsequent pregnancies accordingly.
Offer counseling at a suitable interval of 18 to 24 months between pregnancies.
Counsel women about the increased maternal–fetal risk of preterm birth with assisted reproductive techniques.
Ultrasound assessment of uterine anatomy should be recommended for women planning to conceive.
Evaluate the history of cervical procedures to ensure counseling about the risks of preterm birth and to ensure proper follow‐up during pregnancy.
Pre‐existing conditions
Confirm proper management of existing conditions before making attempts for pregnancy.
Assess carbohydrate intolerance and insulin resistance in every woman with a family history of diabetes.
Detect subclinical hypothyroidism, isolated hypothyroxinemia, and thyroid peroxidase antibody positivity in every reproductive‐age woman and provide counseling about the need for an appropriate approach and treatment before pregnancy.
Mental health issues
Ensure systematic screening for mental health and neurodevelopmental disorders in individuals of reproductive age, followed by access to appropriate therapeutic interventions and psychosocial support.
Assess the presence of eating disorders in all reproductive‐age individuals and promote an interdisciplinary approach, including nutritional, psychological, and social care, alongside timely treatment before planning pregnancy.
Nutrition and nutrient deficiencies
Counsel all women with a BMI below 19 and over 30 about their significantly heightened risk of preterm birth and determine an interdisciplinary approach (nutritional, psychological, and social) and appropriate treatment before attempting pregnancy.
Encourage every reproductive‐age woman to maintain a normal weight and improve nutritional habits.
Detect and treat iron deficiency and anemia in every reproductive‐age woman.
Lifestyle variables
Enquire about alcohol, tobacco, and other substance abuse, and assess an interdisciplinary approach (medical, psychological, and social), as well as appropriate treatment before attempting pregnancy.
Enquire about physical (e.g., high workload, long working hours, shift work, and whole‐body vibration) and psychological demands (fatigue, stress, sleep deprivation, and circadian rhythm disruption) at work for all women of reproductive age, assess an interdisciplinary approach focusing on psychological and social aspects, and provide appropriate counseling to improve working conditions before attempting pregnancy.
Infections
Enquire about HPV vaccination and test for HPV in every reproductive‐age woman and provide counseling about the need for an appropriate approach and treatment before pregnancy.
Ensure appropriate screening and treatment of sexually transmitted diseases in all women of reproductive age and their partners to prevent preterm birth through congenital infection.
Depending on the local prevalence, ensure appropriate screening for seropositivity for CMV and Toxoplasma gondii in all women of reproductive age to prevent preterm birth and perinatal morbidity through congenital infection.
Ensure appropriate detection and treatment of vector‐borne diseases in all women of reproductive age, according to local prevalence.
Encourage every woman of reproductive age to preserve oral health through education and professional assistance.
Socioeconomic issues
Ask every woman of reproductive age about partners or any form of domestic or sexual violence that might be affecting her life; assess an interdisciplinary approach focusing on psychological and social aspects, and provide appropriate counseling to improve conditions before attempting pregnancy.
Ask every woman of reproductive age about her life conditions to detect social issues such as being unhoused, assess an interdisciplinary approach (medical, nutritional, psychological, social), and provide appropriate counseling to improve conditions before attempting pregnancy.
6. THE ROLE OF HEALTH POLICIES AND ADVOCACY IN PRECONCEPTION CARE
Policy and advocacy efforts are crucial for reducing preterm birth rates worldwide. To effectively address this issue, we need comprehensive strategies that include improved public health education and tackling social determinants of health.
Prioritizing preterm labor and preconception care in agendas, developing supportive policies for women, and implementing strong regulations on substances are essential steps in preventing preterm labor and improving outcomes for both mothers and infants.
Ongoing research, funding, and collaboration among governments, healthcare professionals, and advocacy organizations are vital for reducing preterm birth rates significantly.
7. CONCLUSION
Preterm birth is one of the main issues of Maternal–Perinatal Public Health, being responsible for most neonatal and infant deaths, as well as the loss of human capital in terms of the global burden of disease. Considering that an unplanned pregnancy is a high‐risk event for mother and child, health providers should have functional tools for risk assessment, counseling, and intervention before it happens.
Integrating a baby‐centered assessment into preconception care represents a proactive strategy to optimize maternal and perinatal outcomes. Emerging evidence suggests that targeting fetal health considerations before conception can reduce the incidence of preterm births and improve pregnancy trajectories overall.
AUTHOR CONTRIBUTIONS
The FIGO Committee for Preterm Birth prioritized the concept and idea for the paper. LIO wrote the first draft, CMVG and NC wrote the following drafts and corrections, and all authors revised subsequent versions of the manuscript. All authors commented on the manuscript and approved the final version. All committee members reviewed the manuscript before submission.
FUNDING INFORMATION
The authors did not receive support from any organization for the submitted work.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
MEMBERS OF THE FIGO COMMITTEE FOR PRE TERM BIRTH, 2023–2025
Catalina M. Valencia González (Chair), Dilly Anumba, Wondimu Gudu, Bo Jacobsson, Nancy Sierra Lozada, Leticia Ojeda, Madhuri Patel, Andrew Shennan, Rodrigo Rigoni, Priya Soma‐Pillay, Sherri Ann Suplido. Associate Members: Ana Daneva, Sikolia Wanyonyi, Haim Abenhaim.
Ojeda LI, Valencia G CM, Cardozo Buitrago N, et al. FIGO good practice recommendations on preconception care: A strategy to prevent preterm birth. Int J Gynecol Obstet. 2025;171:574‐587. doi: 10.1002/ijgo.70495
[Correction added on 02 Sep 2025, after first online publication: the language was modified throughout the article to improve readability.].
Contributor Information
Catalina M. Valencia, Email: catalina.valencia@medicinafetal.com.co.
the FIGO Committee for Preterm Birth:
Catalina M. Valencia González, Dilly Anumba, Wondimu Gudu, Bo Jacobsson, Nancy Sierra Lozada, Leticia Ojeda, Madhuri Patel, Andrew Shennan, Rodrigo Rigoni, Priya Soma‐Pillay, Sherri Ann Suplido, Ana Daneva, Sikolia Wanyonyi, and Haim Abenhaim
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
REFERENCES
- 1. Born Too Soon: Decade of Action on Preterm Birth. 1st ed. World Health Organization; 2023. [Google Scholar]
- 2. World Health Organization . Meeting to Develop a Global Consensus on Preconception Care to Reduce Maternal and Childhood Mortality and Morbidity: World Health Organization Headquarters, Geneva, 6–7 February 2012: meeting report. World Health Organization; 2013. [Google Scholar]
- 3. Benedetto C, Borella F, Divakar H, et al. FIGO preconception checklist: preconception care for mother and baby. Int J Gynecol Obstet. 2024;165:1‐8. doi: 10.1002/ijgo.15446 [DOI] [PubMed] [Google Scholar]
- 4. Maheshwari MV, Khalid N, Patel PD, Alghareeb R, Hussain A. Maternal and neonatal outcomes of adolescent pregnancy: a narrative review. Cureus. 2022;14:e25921. doi: 10.7759/cureus.25921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Almeida AHDVD, Gama SGND, Costa MCO, et al. Prematuridade e gravidez na adolescência no Brasil, 2011‐2012. Cad Saude Publica. 2020;36:e00145919. doi: 10.1590/0102-311x00145919 [DOI] [PubMed] [Google Scholar]
- 6. Tarlatzis BC, Zepiridis L. Perimenopausal Conception. Ann N Y Acad Sci. 2003;997:93‐104. doi: 10.1196/annals.1290.011 [DOI] [PubMed] [Google Scholar]
- 7. Frederiksen LE, Ernst A, Brix N, et al. Risk of adverse pregnancy outcomes at advanced maternal age. Obstet Gynecol. 2018;131:457‐463. doi: 10.1097/AOG.0000000000002504 [DOI] [PubMed] [Google Scholar]
- 8. Fuchs F, Monet B, Ducruet T, Chaillet N, Audibert F. Effect of maternal age on the risk of preterm birth: a large cohort study. PLoS One. 2018;13:e0191002. doi: 10.1371/journal.pone.0191002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Frick AP. Advanced maternal age and adverse pregnancy outcomes. Best Pract Res Clin Obstet Gynaecol. 2021;70:92‐100. doi: 10.1016/j.bpobgyn.2020.07.005 [DOI] [PubMed] [Google Scholar]
- 10. Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol. 2004;104:727‐733. doi: 10.1097/01.AOG.0000140682.63746.be [DOI] [PubMed] [Google Scholar]
- 11. Khatibi A, Nybo Andersen A‐M, Gissler M, Morken NH, Jacobsson B. Obstetric and neonatal outcome in women aged 50 years and up: a collaborative, Nordic population‐based study. Eur J Obstet Gynecol Reprod Biol. 2018;224:17‐20. doi: 10.1016/j.ejogrb.2018.03.001 [DOI] [PubMed] [Google Scholar]
- 12. Kazemier B, Buijs P, Mignini L, et al. Impact of obstetric history on the risk of spontaneous preterm birth in singleton and multiple pregnancies: a systematic review. BJOG. 2014;121:1197‐1208. doi: 10.1111/1471-0528.12896 [DOI] [PubMed] [Google Scholar]
- 13. Edlow AG, Srinivas SK, Elovitz MA. Second‐trimester loss and subsequent pregnancy outcomes: what is the real risk? Am J Obstet Gynecol. 2007;197:581.e1‐581.e6. doi: 10.1016/j.ajog.2007.09.016 [DOI] [PubMed] [Google Scholar]
- 14. Hernandez‐Diaz S, Toh S, Cnattingius S. Risk of pre‐eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009;338:b2255. doi: 10.1136/bmj.b2255 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Souza RT, Cecatti JG, Passini R, et al. The burden of provider‐initiated preterm birth and associated factors: evidence from the Brazilian multicenter study on preterm birth (EMIP). PLoS One. 2016;11:e0148244. doi: 10.1371/journal.pone.0148244 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Watson HA, Carter J, David AL, Seed PT, Shennan AH. Full dilation cesarean section: a risk factor for recurrent second‐trimester loss and preterm birth. Acta Obstet Gynecol Scand. 2017;96:1100‐1105. doi: 10.1111/aogs.13160 [DOI] [PubMed] [Google Scholar]
- 17. Suff N, Xu VX, Glazewska‐Hallin A, Carter J, Brennecke S, Shennan A. Previous term emergency caesarean section is a risk factor for recurrent spontaneous preterm birth: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2022;271:108‐111. doi: 10.1016/j.ejogrb.2022.02.008 [DOI] [PubMed] [Google Scholar]
- 18. Wen X, Liang W, Zhai J, Wang Y, Zheng P, Wang S. The association between interpregnancy intervals and preterm birth: a systematic review and meta‐analysis. BMC Pregnancy Childbirth. 2025;25:226. doi: 10.1186/s12884-025-07259-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Mignini L, Carroli G, Betran A, et al. Interpregnancy interval and perinatal outcomes across Latin America from 1990 to 2009: a large multi‐country study. BJOG. 2016;123:730‐737. doi: 10.1111/1471-0528.13625 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Conde‐Agudelo A, Rosas‐Bermúdez A, Kafury‐Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta‐analysis. JAMA. 2006;295:1809‐1823. doi: 10.1001/jama.295.15.1809 [DOI] [PubMed] [Google Scholar]
- 21. Salmeri N, Alteri A, Farina A, et al. Preterm birth in singleton pregnancies conceived by in vitro fertilization or intracytoplasmic sperm injection: an overview of systematic reviews. Am J Obstet Gynecol. 2024;231:501‐515.e9. doi: 10.1016/j.ajog.2024.05.037 [DOI] [PubMed] [Google Scholar]
- 22. Li J, Shen J, Zhang X, et al. Risk factors associated with preterm birth after IVF/ICSI. Sci Rep. 2022;12:7944. doi: 10.1038/s41598-022-12149-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Esposito G, Cipriani S, Noli S, et al. The changing impact of assisted reproductive techniques on preterm birth during the period 2007–2020 in Lombardy, Northern Italy. Eur J Obstet Gynecol Reprod Biol. 2022;278:51‐56. doi: 10.1016/j.ejogrb.2022.09.003 [DOI] [PubMed] [Google Scholar]
- 24. Ma S, Peng Y, Hu L, et al. Comparisons of benefits and risks of single embryo transfer versus double embryo transfer: a systematic review and meta‐analysis. Reprod Biol Endocrinol. 2022;20:20. doi: 10.1186/s12958-022-00899-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Mol BW, Jacobsson B, Grobman WA, Moley K, the FIGO Working Group for Preterm Birth . FIGO good practice recommendations on reduction of preterm birth in pregnancies conceived by assisted reproductive technologies. Int J Gynecol Obstet. 2021;155:13‐15. doi: 10.1002/ijgo.13834 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Fox NS, Roman AS, Stern EM, Gerber RS, Saltzman DH, Rebarber A. Type of congenital uterine anomaly and adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2014;27:949‐953. doi: 10.3109/14767058.2013.847082 [DOI] [PubMed] [Google Scholar]
- 27. Hughes KM, Kane SC, Haines TP, Sheehan PM. Cervical length surveillance for predicting spontaneous preterm birth in women with uterine anomalies: a cohort study. Acta Obstet Gynecol Scand. 2020;99:1519‐1526. doi: 10.1111/aogs.13923 [DOI] [PubMed] [Google Scholar]
- 28. Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine‐Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011;38:371‐382. doi: 10.1002/uog.10056 [DOI] [PubMed] [Google Scholar]
- 29. Conner SN, Frey HA, Cahill AG, Macones GA, Colditz GA, Tuuli MG. Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta‐analysis. Obstet Gynecol. 2014;123:752‐761. doi: 10.1097/AOG.0000000000000174 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Wiik J, Kärrberg C, Nilsson S, Strander B, Jacobsson B, Sengpiel V. Associations between cervical intraepithelial neoplasia during pregnancy, previous excisional treatment, cone‐length and preterm delivery: a register‐based study from western Sweden. BMC Med. 2022;20:61. doi: 10.1186/s12916-022-02276-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Kacerovsky M, Musilova I, Baresova S, et al. Cervical excisional treatment increases the risk of intraamniotic infection in subsequent pregnancy complicated by preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2023;229:51.e1‐51.e13. doi: 10.1016/j.ajog.2022.12.316 [DOI] [PubMed] [Google Scholar]
- 32. Park J‐Y, Kim D‐Y, Suh D‐S, et al. Reproductive outcomes after laparoscopic radical trachelectomy for early‐stage cervical cancer. J Gynecol Oncol. 2014;25:9‐13. doi: 10.3802/jgo.2014.25.1.9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Malaza N, Masete M, Adam S, Dias S, Nyawo T, Pheiffer C. A systematic review to compare adverse pregnancy outcomes in women with pregestational diabetes and gestational diabetes. Int J Environ Res Public Health. 2022;19:10846. doi: 10.3390/ijerph191710846 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Greco E, Calanducci M, Nicolaides KH, Barry EVH, Huda MSB, Iliodromiti S. Gestational diabetes mellitus and adverse maternal and perinatal outcomes in twin and singleton pregnancies: a systematic review and meta‐analysis. Am J Obstet Gynecol. 2024;230:213‐225. doi: 10.1016/j.ajog.2023.08.011 [DOI] [PubMed] [Google Scholar]
- 35. Wahabi HA, Fayed A, Esmaeil S, et al. Systematic review and meta‐analysis of the effectiveness of pre‐pregnancy care for women with diabetes for improving maternal and perinatal outcomes. PLoS One. 2020;15:e0237571. doi: 10.1371/journal.pone.0237571 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Sheehan PM, Nankervis A, Araujo Júnior E, da Silva Costa F. Maternal thyroid disease and preterm birth: systematic review and meta‐analysis. J Clin Endocrinol Metab. 2015;100:4325‐4331. doi: 10.1210/jc.2015-3074 [DOI] [PubMed] [Google Scholar]
- 37. The Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth , Korevaar TIM, Derakhshan A, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta‐analysis. JAMA. 2019;322:632‐641. doi: 10.1001/jama.2019.10931 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Stagnaro‐Green A. Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab. 2009;94:21‐25. doi: 10.1210/jc.2008-1288 [DOI] [PubMed] [Google Scholar]
- 39. Vissenberg R, Van Den Boogaard E, Van Wely M, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2012;18:360‐373. doi: 10.1093/humupd/dms007 [DOI] [PubMed] [Google Scholar]
- 40. Reid SM, Middleton P, Cossich MC, et al. Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database Syst Rev. 2013;2013:CD007752. doi: 10.1002/14651858.CD007752.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Maraka S, Ospina NMS, O'Keeffe DT, et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta‐analysis. Thyroid. 2016;26:580‐590. doi: 10.1089/thy.2015.0418 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Yin W, Ludvigsson JF, Åden U, et al. Paternal and maternal psychiatric history and risk of preterm and early term birth: a nationwide study using Swedish registers. PLoS Med. 2023;20:e1004256. doi: 10.1371/journal.pmed.1004256 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Vollrath ME, Sengpiel V, Landolt MA, Jacobsson B, Latal B. Is maternal trait anxiety a risk factor for late preterm and early term deliveries? BMC Pregnancy Childbirth. 2016;16:286. doi: 10.1186/s12884-016-1070-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Mantel Ä, Hirschberg AL, Stephansson O. Association of maternal eating disorders with pregnancy and neonatal outcomes. JAMA Psychiatry. 2020;77:285‐293. doi: 10.1001/jamapsychiatry.2019.3664 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Cornish RP, Magnus MC, Urhoj SK, et al. Maternal pre‐pregnancy body mass index and risk of preterm birth: a collaboration using large routine health datasets. BMC Med. 2024;22:10. doi: 10.1186/s12916-023-03230-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Lefizelier E, Misbert E, Brooks M, le Thuaut A, Winer N, Ducarme G. Preterm birth and small‐for‐gestational age neonates among prepregnancy underweight women: a case‐controlled study. J Clin Med. 2021;10:5733. doi: 10.3390/jcm10245733 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Girsen A, Mayo J, Carmichael S, et al. Women's prepregnancy underweight as a risk factor for preterm birth: a retrospective study. BJOG. 2016;123:2001‐2007. doi: 10.1111/1471-0528.14027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Han Z, Mulla S, Beyene J, Liao G, McDonald S, Knowledge Synthesis Group . Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta‐analyses. Int J Epidemiol. 2011;40:65‐101. doi: 10.1093/ije/dyq195 [DOI] [PubMed] [Google Scholar]
- 49. Dodd JM, Louise J, Deussen AR, Mitchell M, Poston L. Rethinking causal assumptions about maternal BMI, gestational weight gain, and adverse pregnancy outcomes. BMC Med. 2024;22:197. doi: 10.1186/s12916-024-03410-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Cnattingius S, Villamor E, Johansson S, et al. Maternal obesity and risk of preterm delivery. JAMA. 2013;309:2362. doi: 10.1001/jama.2013.6295 [DOI] [PubMed] [Google Scholar]
- 51. Slack E, Best KE, Rankin J, Heslehurst N. Maternal obesity classes, preterm and post‐term birth: a retrospective analysis of 479,864 births in England. BMC Pregnancy Childbirth. 2019;19:434. doi: 10.1186/s12884-019-2585-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Englund‐Ogge L, Brantsaeter AL, Sengpiel V, et al. Maternal dietary patterns and preterm delivery: results from large prospective cohort study. BMJ. 2014;348:g1446. doi: 10.1136/bmj.g1446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Gould JB, Mayo J, Shaw GM, Stevenson DK, the March of Dimes Prematurity Research Center at Stanford University School of Medicine . Swedish and American studies show that initiatives to decrease maternal obesity could play a key role in reducing preterm birth. Acta Paediatr. 2014;103:586‐591. doi: 10.1111/apa.12616 [DOI] [PubMed] [Google Scholar]
- 54. Rahmati S, Azami M, Badfar G, Parizad N, Sayehmiri K. The relationship between maternal anemia during pregnancy with preterm birth: a systematic review and meta‐analysis. J Matern Fetal Neonatal Med. 2020;33:2679‐2689. doi: 10.1080/14767058.2018.1555811 [DOI] [PubMed] [Google Scholar]
- 55. Khezri R, Salarilak S, Jahanian S. The association between maternal anemia during pregnancy and preterm birth. Clin Nutr ESPEN. 2023;56:13‐17. doi: 10.1016/j.clnesp.2023.05.003 [DOI] [PubMed] [Google Scholar]
- 56. World Health Organization . Guideline: intermittent iron and folic acid supplementation in menstruating women 2011. [PubMed]
- 57. Sun L, Li Y, Xie W, Xue X. Association between omega‐3 fatty acid supplementation and lower risk of preterm delivery: a systematic review and meta‐analysis. J Matern Fetal Neonatal Med. 2022;35:2294‐2303. doi: 10.1080/14767058.2020.1785423 [DOI] [PubMed] [Google Scholar]
- 58. Makrides M, Best K, Yelland L, et al. A randomized trial of prenatal n−3 fatty acid supplementation and preterm delivery. N Engl J Med. 2019;381:1035‐1045. doi: 10.1056/NEJMoa1816832 [DOI] [PubMed] [Google Scholar]
- 59. Samuel TM, Sakwinska O, Makinen K, Burdge GC, Godfrey KM, Silva‐Zolezzi I. Preterm birth: a narrative review of the current evidence on nutritional and bioactive solutions for risk reduction. Nutrients. 2019;11:1811. doi: 10.3390/nu11081811 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Nabet C, Lelong N, Ancel P‐Y, Saurel‐Cubizolles MJ, Kaminski M. Smoking during pregnancy according to obstetric complications and parity: results of the EUROPOP study. Eur J Epidemiol. 2007;22:715‐721. doi: 10.1007/s10654-007-9172-8 [DOI] [PubMed] [Google Scholar]
- 61. Kyrklund‐Blomberg NB, Granath F, Cnattingius S. Maternal smoking and causes of very preterm birth. Acta Obstet Gynecol Scand. 2005;84:572‐577. doi: 10.1111/j.0001-6349.2005.00848.x [DOI] [PubMed] [Google Scholar]
- 62. Wilson CA, Finch E, Kerr C, Shakespeare J. Alcohol, smoking, and other substance use in the perinatal period. BMJ. 2020;369:m1627. doi: 10.1136/bmj.m1627 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Quesada O, Gotman N, Howell HB, Funai EF, Rounsaville BJ, Yonkers KA. Prenatal hazardous substance use and adverse birth outcomes. J Matern Fetal Neonatal Med. 2012;25:1222‐1227. doi: 10.3109/14767058.2011.602143 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Janisse JJ, Bailey BA, Ager J, Sokol RJ. Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abus. 2014;35:60‐67. doi: 10.1080/08897077.2013.804483 [DOI] [PubMed] [Google Scholar]
- 65. Juhl M, Andersen PK, Olsen J, et al. Physical exercise during pregnancy and the risk of preterm birth: a study within the Danish National Birth Cohort. Am J Epidemiol. 2008;167:859‐866. doi: 10.1093/aje/kwm364 [DOI] [PubMed] [Google Scholar]
- 66. Jones AJ, Eke UA, Eke AC. Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy. Expert Rev Anti‐Infect Ther. 2022;20:837‐848. doi: 10.1080/14787210.2022.2046463 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Elenga N, Djossou Fé l, Nacher M. Association between maternal human immunodeficiency virus infection and preterm birth: a matched case‐control study from a pregnancy outcome registry. Medicine (Baltimore). 2021;100:e22670. doi: 10.1097/MD.0000000000022670 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV‐infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis. 2012;54:1348‐1360. doi: 10.1093/cid/cis198 [DOI] [PubMed] [Google Scholar]
- 69. Eke AC, Mirochnick M, Lockman S. Antiretroviral therapy and adverse pregnancy outcomes in people living with HIV. N Engl J Med. 2023;388:344‐356. doi: 10.1056/NEJMra2212877 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Siou K, Walmsley SL, Murphy KE, et al. Progesterone supplementation for HIV‐positive pregnant women on protease inhibitor‐based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial. Pilot Feasibility Stud. 2016;2:49. doi: 10.1186/s40814-016-0087-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Eppes CS, Stafford I, Rac M. Syphilis in pregnancy: an ongoing public health threat. Am J Obstet Gynecol. 2022;227:822‐838. doi: 10.1016/j.ajog.2022.07.041 [DOI] [PubMed] [Google Scholar]
- 72. Bajema KL, Stankiewicz Karita HC, Tenforde MW, Hawes SE, Heffron R. Maternal hepatitis B infection and pregnancy outcomes in the United States: a population‐based cohort study. Open Forum Infect Dis. 2018;5:ofy134. doi: 10.1093/ofid/ofy134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Ma X, Sun D, Li C, Ying J, Yan Y. Chronic hepatitis B virus infection and preterm labor(birth) in pregnant women—an updated systematic review and meta‐analysis. J Med Virol. 2018;90:93‐100. doi: 10.1002/jmv.24927 [DOI] [PubMed] [Google Scholar]
- 74. Zheng S, Zhang H, Chen R, Yan J, Han Q. Pregnancy complicated with hepatitis B virus infection and preterm birth: a retrospective cohort study. BMC Pregnancy Childbirth. 2021;21:513. doi: 10.1186/s12884-021-03978-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Niyibizi J, Mayrand M‐H, Audibert F, et al. Association between human papillomavirus infection among pregnant women and preterm birth. JAMA Netw Open. 2021;4:e2125308. doi: 10.1001/jamanetworkopen.2021.25308 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Huang Q, Zhong M, Gao Y, et al. Can HPV vaccine have other health benefits more than cancer prevention? A systematic review of association between cervical HPV infection and preterm birth. J Clin Virol. 2014;61:321‐328. doi: 10.1016/j.jcv.2014.09.002 [DOI] [PubMed] [Google Scholar]
- 77. Wiik J, Nilsson S, Kärrberg C, Strander B, Jacobsson B, Sengpiel V. Associations of treated and untreated human papillomavirus infection with preterm delivery and neonatal mortality: a Swedish population‐based study. PLoS Med. 2021;18:e1003641. doi: 10.1371/journal.pmed.1003641 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Aldhous MC, Bhatia R, Pollock R, et al. HPV infection and pre‐term birth: a data‐linkage study using Scottish Health Data. Wellcome Open Res. 2019;4:48. doi: 10.12688/wellcomeopenres.15140.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Ambühl LMM, Baandrup U, Dybkær K, Blaakær J, Uldbjerg N, Sørensen S. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery. Infect Dis Obstet Gynecol. 2016;2016:1‐19. doi: 10.1155/2016/3086036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Silver BJ, Guy RJ, Kaldor JM, Jamil MS, Rumbold AR. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta‐analysis. Sex Transm Dis. 2014;41:369‐376. doi: 10.1097/OLQ.0000000000000134 [DOI] [PubMed] [Google Scholar]
- 81. Van Gerwen O, Craig‐Kuhn M, Jones A, et al. Trichomoniasis and adverse birth outcomes: a systematic review and meta‐analysis. BJOG. 2021;128:1907‐1915. doi: 10.1111/1471-0528.16774 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Balkus JE, Richardson BA, Rabe LK, et al. Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV‐1–negative women. Sex Transm Dis. 2014;41:123‐128. doi: 10.1097/OLQ.0000000000000075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Xu Y, Hu J, Huang Y, Shi LP. Maternal Ureaplasma exposure during pregnancy and the risk of preterm birth and BPD: a meta‐analysis. Arch Gynecol Obstet. 2022;306:1863‐1872. doi: 10.1007/s00404-022-06491-7 [DOI] [PubMed] [Google Scholar]
- 84. Sprong KE, Mabenge M, Wright CA, Govender S. Ureaplasma species and preterm birth: current perspectives. Crit Rev Microbiol. 2020;46:169‐181. doi: 10.1080/1040841X.2020.1736986 [DOI] [PubMed] [Google Scholar]
- 85. Freeman K, Oakley L, Pollak A, et al. Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG. 2005;112:31‐37. doi: 10.1111/j.1471-0528.2004.00299.x [DOI] [PubMed] [Google Scholar]
- 86. Carmona AS, Kakkar F, Gantt S. Perinatal cytomegalovirus infection. Curr Treat Options Pediatr. 2022;8:395‐411. doi: 10.1007/s40746-022-00261-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Kenneson A, Cannon MJ. Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253‐276. doi: 10.1002/rmv.535 [DOI] [PubMed] [Google Scholar]
- 88. Zakama AK, Ozarslan N, Gaw SL. Placental Malaria. Curr Trop Med Rep. 2020;7:162‐171. doi: 10.1007/s40475-020-00213-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Mahamar A, Andemel N, Swihart B, et al. Malaria infection is common and associated with perinatal mortality and preterm delivery despite widespread use of chemoprevention in Mali: an observational study 2010 to 2014. Clin Infect Dis. 2021;73:1355‐1361. doi: 10.1093/cid/ciab301 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Hussein H, Shamsipour M, Yunesian M, et al. Prenatal malaria exposure and risk of adverse birth outcomes: a prospective cohort study of pregnant women in the northern region of Ghana. BMJ Open. 2022;12:e058343. doi: 10.1136/bmjopen-2021-058343 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Barbosa CG, Gómez‐Hernández C, Da Silva MV, et al. Congenital transmission of Mexican strains of Trypanosoma cruzi TcIa: interaction between parasite and human placental explants. Parasitology. 2022;149:418‐426. doi: 10.1017/S0031182021002018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Rathore SS, Oberoi S, Hilliard J, et al. Maternal and foetal‐neonatal outcomes of dengue virus infection during pregnancy. Trop Med Int Health. 2022;27:619‐629. doi: 10.1111/tmi.13783 [DOI] [PubMed] [Google Scholar]
- 93. Cooper HJ, Iwamoto M, Lash M, et al. Maternal zika virus infection: association with small‐for‐gestational‐age neonates and preterm birth. Obstet Gynecol. 2019;134:1197‐1204. doi: 10.1097/AOG.0000000000003577 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. López NJ, Da Silva I, Ipinza J, et al. Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy‐associated gingivitis. J Periodontol. 2005;76:2144‐2153. doi: 10.1902/jop.2005.76.11-S.2144 [DOI] [PubMed] [Google Scholar]
- 95. Jeffcoat M, Parry S, Sammel M, Clothier B, Catlin A, Macones G. Periodontal infection and preterm birth: successful periodontal therapy reduces the risk of preterm birth. BJOG. 2011;118:250‐256. doi: 10.1111/j.1471-0528.2010.02713.x [DOI] [PubMed] [Google Scholar]
- 96. Adane HA, Iles R, Boyle JA, Gelaw A, Collie A. Maternal occupational risk factors and preterm birth: a systematic review and meta‐analysis. Public Health Rev. 2023;44:1606085. doi: 10.3389/phrs.2023.1606085 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Eyeberu A, Alemu A, Debella A, Mussa I. Is intimate partner violence and obstetrics characteristics of pregnant women associated with preterm birth in Ethiopia? Umbrella review on preterm birth. Reprod Health. 2023;20:168. doi: 10.1186/s12978-023-01716-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Henriksen L, Vangen S, Schei B, Lukasse M. Sexual violence and antenatal hospitalization. Birth. 2013;40:281‐288. doi: 10.1111/birt.12063 [DOI] [PubMed] [Google Scholar]
- 99. Green JM, Fabricant SP, Duval CJ, et al. Trends, characteristics, and maternal morbidity associated with unhoused status in pregnancy. JAMA Netw Open. 2023;6:e2326352. doi: 10.1001/jamanetworkopen.2023.26352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Khanam R, Kumar I, Oladapo‐Shittu O, et al. Prenatal environmental metal exposure and preterm birth: a scoping review. Int J Environ Res Public Health. 2021;18:573. doi: 10.3390/ijerph18020573 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Cantonwine D, Meeker JD, Hu H, et al. Bisphenol a exposure in Mexico City and risk of prematurity: a pilot nested case control study. Environ Health. 2010;9:62. doi: 10.1186/1476-069X-9-62 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Huang S, Li J, Xu S, et al. Bisphenol A and bisphenol S exposures during pregnancy and gestational age—a longitudinal study in China. Chemosphere. 2019;237:124426. doi: 10.1016/j.chemosphere.2019.124426 [DOI] [PubMed] [Google Scholar]
- 103. Zhang Y, Mustieles V, Yland J, et al. Association of parental preconception exposure to phthalates and phthalate substitutes with preterm birth. JAMA Netw Open. 2020;3:e202159. doi: 10.1001/jamanetworkopen.2020.2159 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Welch BM, Keil AP, Buckley JP, et al. Associations between prenatal urinary biomarkers of phthalate exposure and preterm birth: a pooled study of 16 US cohorts. JAMA Pediatr. 2022;176:895‐905. doi: 10.1001/jamapediatrics.2022.2252 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Bouchard MF, Chevrier J, Harley KG, et al. Prenatal exposure to organophosphate pesticides and IQ in 7‐year‐old children. Environ Health Perspect. 2011;119:1189‐1195. doi: 10.1289/ehp.1003185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106. Kolan AS, Hall JM. Association of preterm birth and exposure to endocrine disrupting chemicals. Int J Mol Sci. 2023;24:1952. doi: 10.3390/ijms24031952 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Eskenazi B, Harley K, Bradman A, et al. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect. 2004;112:1116‐1124. doi: 10.1289/ehp.6789 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Jaacks LM, Diao N, Calafat AM, et al. Association of prenatal pesticide exposures with adverse pregnancy outcomes and stunting in rural Bangladesh. Environ Int. 2019;133:105243. doi: 10.1016/j.envint.2019.105243 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. Wang P, Tian Y, Wang X‐J, et al. Organophosphate pesticide exposure and perinatal outcomes in Shanghai, China. Environ Int. 2012;42:100‐104. doi: 10.1016/j.envint.2011.04.015 [DOI] [PubMed] [Google Scholar]
- 110. Farhang L, Weintraub JM, Petreas M, Eskenazi B, Bhatia R. Association of DDT and DDE with birth weight and length of gestation in the child health and development studies, 1959–1967. Am J Epidemiol. 2005;162:717‐725. doi: 10.1093/aje/kwi276 [DOI] [PubMed] [Google Scholar]
- 111. Anand M, Singh L, Agarwal P, Saroj R, Taneja A. Pesticides exposure through environment and risk of pre‐term birth: a study from Agra city. Drug Chem Toxicol. 2019;42:471‐477. doi: 10.1080/01480545.2017.1413107 [DOI] [PubMed] [Google Scholar]
- 112. Chen L, Wang C, Cui C, et al. Prenatal exposure to polybrominated diphenyl ethers and birth outcomes. Environ Pollut. 2015;206:32‐37. doi: 10.1016/j.envpol.2015.06.019 [DOI] [PubMed] [Google Scholar]
- 113. Harley KG, Chevrier J, Schall RA, Sjodin A, Bradman A, Eskenazi B. Association of prenatal exposure to polybrominated diphenyl ethers and infant birth weight. Am J Epidemiol. 2011;174:885‐892. doi: 10.1093/aje/kwr212 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Atrash HK, Johnson K, Adams M, Cordero JF, Howse J. Preconception care for improving perinatal outcomes: the time to act. Matern Child Health J. 2006;10:3‐11. doi: 10.1007/s10995-006-0100-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Henderson JT, Hudson Scholle S, Weisman CS, Anderson RT. The role of physician gender in the evaluation of the National Centers of Excellence in Women's Health: test of an alternate hypothesis. Womens Health Issues. 2004;14:130‐139. doi: 10.1016/j.whi.2004.04.005 [DOI] [PubMed] [Google Scholar]
- 116. Barash JH, Weinstein LC. Preconception and prenatal care. Prim Care. 2002;29:519‐542. doi: 10.1016/S0095-4543(02)00013-1 [DOI] [PubMed] [Google Scholar]
- 117. Brundage SC. Preconception health care. J S C Med Assoc 1975. 2002;98:253‐254. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
